Michal Kovo

TL;DR: The BNT162b2 mRNA vaccine elicits strong maternal humoral IgG response (anti-S and RBD) that crosses the placenta barrier and approaches maternal titers in the fetus within 15 days following the first dose as discussed by the authors.

TL;DR: Pregnancy-induced hypertension/preeclampsia and fetal growth restriction share a common placental origin, and placental lesions correspond with different clinical presentations.

TL;DR: To identify pathological placental differences between early‐onset and late-onset preeclampsia, in relation to fetal growth restriction (FGR), the objective was to establish a phylogenetic relationship between FGR and placental differentiation.

TL;DR: The relative new categorization of the placental lesions, separating the non-infectious lesions into lesions that are consistent with maternal and fetal circulation abnormalities, and the infectious lesions into maternal and Fetal inflammatory responses, provides an additional tool to determine the placents maternal andfetal role in the various pregnancy complications.

TL;DR: Early- and late-onset FGR have different placental pathology compared with AGA controls, suggesting that a combination of fetal and maternal vascular compromise is more dominant in the late-onset FGR, rather than more severe maternal vascular compromised in early-onsett FGR.